Greenrise Global Brands Inc. (XCX.CN)

0.0500 -0.0100 (-16.67%) At close: 10:42AM EST

Greenrise Global Brands Inc.

925 West Georgia Street
Suite 1000
Vancouver, BC V6C 3L2
Canada

https://greenriseglobal.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Stefan Feuerstein	Pres, CEO, Interim CFO & Director	270.24k	N/A	N/A
Ms. Christine McPhie	Corp. Sec.	N/A	N/A	1962
Mr. Marc Walken	Sales Director	N/A	N/A	N/A
Dr. Stefan Stromeier	Head of Quality Control	N/A	N/A	N/A
Dr. Atila Basoglu	Head of Production	N/A	N/A	N/A

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Greenrise Global Brands Inc., through its subsidiaries, operates as a pharmaceutical supplier of medical cannabis products to pharmacies in Germany. It offers a range of CBD products consisting of tinctures, sprays, oils, and skincare products through drugstores; and imports and sells EU-GMP medical and cosmetic cannabis products. The company was formerly known as AMP Alternative Medical Products Inc. and changed its name to Greenrise Global Brands Inc. in November 2021. Greenrise Global Brands Inc. is based in Vancouver, Canada.

Corporate Governance

Greenrise Global Brands Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.